Conor Steuer, MD

One star
One star
One star
One star
One half star

Rating: 4.7 out of 5 (159 ratings)

Role

Medical Oncology
Specialty

Head and Neck Cancer Lung Cancer Thyroid Cancer Esophageal Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2015

Request Appointment

Background

Conor E. Steuer, MD, is an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Steuer is a medical oncologist specializing in the care of aerodigestive cancers, mesothelioma and thymic malignancies. He joined the clinical staff at Winship Cancer Institute as a practicing physician in July 2015.

Dr. Steuer received his medical degree from NYU School of Medicine. He completed his postdoctoral training as a Fellow in the Department of Hematology and Medical Oncology at Emory University School of Medicine where he was Chief Fellow in his final year.

Titles & Roles

Associate Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, Hematology & Oncology, 2015
Emory University School of Medicine
Residency, Internal Medicine, 2012
Emory University School of Medicine
Medical Education, , 2009
New York University

Board Certifications

Medical Oncology
American Board of Internal Medicine, 2015
Hematology
American Board of Internal Medicine, 2015
Internal Medicine
American Board of Internal Medicine, 2012

View Current Clinical Trials


Testing the Anti-Cancer Drug Darolutamide in Patients With Testosterone-driven Salivary Gland Cancers Phase II Conditions Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Unresectable Salivary Gland Carcinoma Location Emory University Hospital Midtown
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) for Recurrent, Metastatic, or Unresectable HER2-Positive Salivary Gland Cancer Phase II Conditions Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8, Stage IV Major Salivary Gland Cancer AJCC v8, Unresectable Salivary Gland Carcinoma Location Emory University Hospital Midtown
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy Phase III Conditions Nonsquamous Non-small Cell Lung Cancer, EGFR L858R, EGFR Exon 19 Deletion Location Emory University Hospital Midtown, Winship Cancer Institute
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation Phase I/II Conditions KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung, Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary, Pulmonary Cancer, Pulmonary Neoplasms Location Winship Cancer Institute
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) Phase I Conditions Solid Tumor, Non-Small Cell Lung Cancer, Melanoma, Head and Neck Cancer, Gastric Cancer, Renal Cell Carcinoma, Urothelial Carcinoma Location Winship Cancer Institute
VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer Phase I Conditions Squamous Cell Carcinoma of the Head and Neck Location Emory University Hospital Midtown, Winship Cancer Institute
HER3-DXd in Metastatic or Unresectable Non-Small Cell Lung Cancer Phase I Conditions Non-Small Cell Lung Cancer (NSCLC) Location Winship Cancer Institute

Title/Journal	Authors	Publication Date
Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage. Head & neck	S Pamulapati, M Abousaud, Y Li, A Ekpenyong, S Rudra, JS Remick, JE Bates, WA Stokes, MW McDonald, NC Schmitt, MW El-Deiry, MR Patel, CE Steuer, JM Switchenko, DM Shin, Y Teng, A Hammond, NF Saba	02/05/2024
HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI. Future oncology (London, England)	T Mok, PA Jänne, M Nishio, S Novello, M Reck, C Steuer, YL Wu, R Fougeray, PD Fan, J Meng, DW Sternberg, S Esker, HA Yu	01/05/2024
Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement. The Laryngoscope	RJ So, JC Hidalgo Lopez, SA Ballestas, AM Klein, C Steuer, DM Shin, M Abousaud, Y Teng, NF Saba, AT Tkaczuk, ES Schaefer, TY Seiwert, K McClellan, SR Best	01/02/2024
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancer. Cancer	NS McCall, JR Janopaul-Naylor, HS McGinnis, AH Kesarwala, S Tian, WA Stokes, JW Shelton, CE Steuer, JW Carlisle, TA Leal, SS Ramalingam, JD Bradley, KA Higgins	01/12/2023
Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis. The Laryngoscope	SA Ballestas, J Hidalgo Lopez, AM Klein, C Steuer, DM Shin, M Abousaud, NC Schmitt, Y Teng, NF Saba, AT Tkaczuk	01/10/2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	JE Bauman, NF Saba, D Roe, JR Bauman, J Kaczmar, A Bhatia, J Muzaffar, R Julian, S Wang, S Bearelly, A Baker, C Steuer, A Giri, B Burtness, S Centuori, C Caulin, R Klein, K Saboda, S Obara, CH Chung	01/08/2023
Patient-reported outcomes in immunotherapy for head and neck cancer. Head & neck	K Kirtane, AI Hoogland, X Li, Y Rodriguez, K Scheel, BJ Small, LB Oswald, J Muzaffar, JA Kish, M Bonomi, P Bhateja, NF Saba, CE Steuer, CH Chung, HSL Jim	01/07/2023
Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research	DS Hong, M Postow, B Chmielowski, R Sullivan, A Patnaik, EEW Cohen, G Shapiro, C Steuer, M Gutierrez, H Yeckes-Rodin, R Ilaria, B O'Connell, J Peng, G Peng, N Zizlsperger, A Tolcher, JD Wolchok	13/06/2023
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial. Nature medicine	NF Saba, CE Steuer, A Ekpenyong, A McCook-Veal, K Magliocca, M Patel, NC Schmitt, W Stokes, JE Bates, S Rudra, J Remick, M McDonald, M Abousaud, AC Tan, MZH Fadlullah, R Chaudhary, J Muzaffar, K Kirtane, Y Liu, GZ Chen, DM Shin, Y Teng, CH Chung	01/04/2023
Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilities. Head & neck	JR Janopaul-Naylor, M Rupji, RA Tobillo, JW Lorenz, JM Switchenko, S Tian, AS Kaka, DC Qian, AJ Schlafstein, CE Steuer, JS Remick, S Rudra, MW McDonald, NF Saba, WA Stokes, MR Patel, JE Bates	01/03/2023
The evolving landscape of salivary gland tumors. CA: a cancer journal for clinicians	CE Steuer, GJ Hanna, K Viswanathan, JE Bates, AS Kaka, NC Schmitt, AL Ho, NF Saba	01/01/2023
Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck. Frontiers in oncology	P Puttagunta, SV Pamulapati, JE Bates, JH Gross, WA Stokes, NC Schmitt, C Steuer, Y Teng, NF Saba	01/01/2023
Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma. ORL; journal for oto-rhino-laryngology and its related specialties	KR Magliocca, AS Kaka, EM Barrow, MB Studer, CC Griffith, J Ernst, T Meade, A Balicki, BJ Boyce, NC Schmitt, AM Bur, AC Schmitt, R Jackson, CE Steuer, JJ Beitler, MR Patel	01/01/2023
Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: "Repeat and replicate". Cancer	CE Steuer, NF Saba	15/12/2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, A Chang, AA McCook-Veal, J Switchenko, TH Nasti, M Saini, A Wieland, KE Manning, M Ellis, KM Moore, SL Foster, K Floyd, ME Davis-Gardner, VV Edara, M Patel, C Steur, AK Nooka, F Green, MA Johns, F O'Brein, U Shanmugasundaram, VI Zarnitsyna, H Ahmed, LE Nyhoff, G Mantus, M Garett, S Edupuganti, M Behra, R Antia, J Wrammert, MS Suthar, MV Dhodapkar, S Ramalingam, R Ahmed	20/11/2022
A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non-Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade. Clinical lung cancer	BE Osta, J Carlisle, C Steuer, S Pakkala, T Leal, M Dhodapkar, Y Liu, Z Chen, T Owonikoko, S Ramalingam	01/11/2022
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	NS McCall, HS McGinnis, JR Janopaul-Naylor, AH Kesarwala, S Tian, WA Stokes, JW Shelton, CE Steuer, JW Carlisle, T Leal, SS Ramalingam, JD Bradley, KA Higgins	01/09/2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research	CH Chung, J Li, CE Steuer, P Bhateja, M Johnson, J Masannat, MI Poole, F Song, JC Hernandez-Prera, H Molina, BM Wenig, S Kumar, C Kuperwasser, PJ Stephens, JM Farinhas, DM Shin, JA Kish, J Muzaffar, K Kirtane, JW Rocco, MJ Schell, NF Saba, M Bonomi	01/06/2022
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma. Journal for immunotherapy of cancer	X Wang, J Muzaffar, K Kirtane, F Song, M Johnson, MJ Schell, J Li, SJ Yoder, JR Conejo-Garcia, JA Guevara-Patino, M Bonomi, P Bhateja, JW Rocco, CE Steuer, NF Saba, CH Chung	01/06/2022
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer. Cancers	JE Bauman, Z Chen, C Zhang, JP Ohr, RL Ferris, GM McGorisk, S Brandt, S Srivatsa, AY Chen, CE Steuer, DM Shin, NF Saba, FR Khuri, TK Owonikoko	26/05/2022
Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab. Oral oncology	DJ Glazar, M Johnson, J Farinhas, CE Steuer, NF Saba, M Bonomi, CH Chung, H Enderling	01/04/2022
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future? Current treatment options in oncology	JE Bates, CE Steuer	01/03/2022
Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas. The oncologist	P Vijayvargiya, S Trivedi, M Rupji, H Song, Y Liu, R Jiang, AS Kaka, GZ Chen, W Stokes, C Steuer, DM Shin, JJ Beitler, MR Patel, A Aiken, NF Saba	03/02/2022
The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures. Head & neck	VR Dhere, CE Escott, S Tian, JM Switchenko, JP Bell, WA Stokes, MW McDonald, KR Magliocca, BJ Boyce, AS Kaka, CE Steuer, NF Saba, DM Shin, C Xiao, MR Patel, JJ Beitler	01/02/2022
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern. medRxiv : the preprint server for health sciences	R Valanparambil, J Carlisle, S Linderman, A Akthar, RL Millett, L Lai, A Chang, A McCook, J Switchenko, T Nasti, M Saini, AW Andreas Wieland, K Manning, M Ellis, K Moore, S Foster, K Floyd, M Davis-Gardner, V Viswanadh Edara, M Patel, C Steur, A Nooka, F Green, M Johns, F O Brein, U Shanmugasundaram, V Zarnitsyna, H Ahmed, L Nyhoff, G Mantus, M Garett, S Edupuganti, M Behra, R Antia, J Wrammert, M Suthar, M Dhodapkar, S Ramalingam, R Ahmed	23/01/2022
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer. Cancer discovery	PA Jänne, C Baik, WC Su, ML Johnson, H Hayashi, M Nishio, DW Kim, M Koczywas, KA Gold, CE Steuer, H Murakami, JC Yang, SW Kim, M Vigliotti, R Shi, Z Qi, Y Qiu, L Zhao, D Sternberg, C Yu, HA Yu	01/01/2022
Advances in Immunotherapy and Implications for Current Practice in Non-Small-Cell Lung Cancer. JCO oncology practice	CE Steuer, SS Ramalingam	01/11/2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors. The oncologist	KT Do, LQM Chow, K Reckamp, RE Sanborn, H Burris, F Robert, DR Camidge, CE Steuer, JH Strickler, A Weise, JM Specht, M Gutierrez, P Haughney, S Hengel, CL Derleth, TA Yap	01/11/2021
Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population--A SEER-based analysis from 2000 to 2016. Cancer medicine	MA Taylor, J Switchenko, W Stokes, MR Patel, M McDonald, C Steuer, A Aiken, JJ Beitler, DM Shin, NF Saba	01/09/2021
Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	F Carsuzaa, M Lapeyre, V Gregoire, P Maingon, A Beddok, PY Marcy, J Salleron, A Coutte, S Racadot, Y Pointreau, P Graff, B Beadle, K Benezery, J Biau, V Calugaru, J Castelli, M Chua, A Di Rito, M Dore, P Ghadjar, F Huguet, P Jardel, J Johansen, R Kimple, M Krengli, S Laskar, L Mcdowell, A Nichols, S Tribius, I Valduvieco, C Hu, X Liem, A Moya-Plana, I D'onofrio, U Parvathaneni, V Takiar, E Orlandi, A Psyrri, G Shenouda, D Sher, C Steuer, X Shan Sun, Y Tao, D Thomson, MH Tsai, N Vulquin, P Gorphe, H Mehanna, SS Yom, J Bourhis, J Thariat	01/07/2021
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer	CE Steuer, OA Jegede, SE Dahlberg, HA Wakelee, SM Keller, WJ Tester, DR Gandara, SL Graziano, AA Adjei, CA Butts, SS Ramalingam, JH Schiller	01/06/2021
TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORS. Oral oncology	MR Patel, L Ottenstein, M Ryan, A Farrell, M Studer, HM Baddour, K Magliocca, C Griffith, W Stokes, J Switchenko, A Aiken, M El-Deiry, CA Solares, C Steuer, N Saba, J Beitler	01/06/2021
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study. Cancers	CH Chung, M Bonomi, CE Steuer, J Li, P Bhateja, M Johnson, J Masannat, F Song, JC Hernandez-Prera, BM Wenig, H Molina, JM Farinhas, CP McMullen, JT Wadsworth, KB Patel, JA Kish, J Muzaffar, K Kirtane, JW Rocco, MJ Schell, NF Saba	09/03/2021
Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma. JCO oncology practice	JA Marks, JM Switchenko, CE Steuer, M Ryan, MR Patel, MW McDonald, K Higgins, JJ Beitler, DM Shin, TW Gillespie, NF Saba	01/03/2021
Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population. The Laryngoscope	A Tkaczuk, S Trivedi, MD Mody, CE Steuer, DM Shin, AM Klein, NF Saba	01/03/2021
Surgical Resection is Justifiable for Oral T4b Squamous Cell Cancers With Masticator Space Invasion. The Laryngoscope	HM Baddour, MC Ochsner, MR Patel, JM Switchenko, JJ Beitler, K Magliocca, KL Baugnon, CA Solares, CE Steuer, MW El-Deiry	01/02/2021
Combinatorial approaches targeting the EGFR family and c-Met in SCCHN. Oral oncology	D Wang, Y Lu, S Nannapaneni, CC Griffith, C Steuer, G Qian, X Wang, Z Chen, M Patel, M El-Deiry, DM Shin, X He, ZG Chen, NF Saba	01/01/2021
Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study. Journal for immunotherapy of cancer	S Pakkala, K Higgins, Z Chen, G Sica, C Steuer, C Zhang, G Zhang, S Wang, MS Hossain, B Nazha, T Beardslee, FR Khuri, W Curran, S Lonial, EK Waller, S Ramalingam, TK Owonikoko	01/12/2020
Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma. The Laryngoscope	DC Qian, KR Magliocca, AH Aiken, KL Baugnon, DC Brandon, WA Stokes, MW McDonald, MR Patel, HM Baddour, AS Kaka, CE Steuer, NF Saba, DM Shin, JJ Beitler	01/12/2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck. Clinical cancer research : an official journal of the American Association for Cancer Research	DM Shin, S Nannapaneni, MR Patel, Q Shi, Y Liu, Z Chen, AY Chen, MW El-Deiry, JJ Beitler, CE Steuer, SM Roser, AM Klein, TK Owonikoko, SS Ramalingam, FR Khuri, ZG Chen, NF Saba	15/11/2020
An update on the immune landscape in lung and head and neck cancers. CA: a cancer journal for clinicians	JW Carlisle, CE Steuer, TK Owonikoko, NF Saba	01/11/2020
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. British journal of cancer	RD Harvey, BC Carthon, C Lewis, MS Hossain, C Zhang, Z Chen, WB Harris, OB Alese, W Shaib, MA Bilen, DH Lawson, C Wu, CE Steuer, BF El-Rayes, FR Khuri, S Lonial, EK Waller, SS Ramalingam, TK Owonikoko	01/10/2020
EGFR tyrosine kinase inhibitors (TKIs) for adjuvant therapy of early-stage non-small cell lung cancer (NSCLC): ready for the clinic? Translational lung cancer research	CE Steuer, SS Ramalingam	01/10/2020
Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis. International journal of radiation oncology, biology, physics	S Tian, JM Switchenko, ZS Buchwald, PR Patel, JW Shelton, SE Kahn, RN Pillai, CE Steuer, TK Owonikoko, M Behera, WJ Curran, KA Higgins	01/09/2020
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research	TK Owonikoko, RD Harvey, B Carthon, Z Chen, C Lewis, H Collins, C Zhang, DH Lawson, OB Alese, MA Bilen, GL Sica, CE Steuer, WL Shaib, C Wu, WB Harris, M Akce, RR Kudchagkar, BF El-Rayes, S Lonial, SS Ramalingam, FR Khuri	01/06/2020
Demographic and Socioeconomic Factors Associated With Metastases at Presentation in HPV-Related Squamous Cell Carcinoma of the Head and Neck: An NCDB Analysis. JCO oncology practice	MB Bean, JM Switchenko, CE Steuer, M Patel, K Higgins, M McDonald, GZ Chen, JJ Beitler, DM Shin, T Gillespie, NF Saba	01/06/2020
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis. The oncologist	M Behera, CE Steuer, Y Liu, F Fernandez, C Fu, KA Higgins, TW Gillespie, S Pakkala, RN Pillai, S Force, CP Belani, FR Khuri, WJ Curran, SS Ramalingam	01/06/2020
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy. The oncologist	MA Bilen, DJ Martini, Y Liu, JM Shabto, JT Brown, M Williams, AI Khan, A Speak, C Lewis, H Collins, HT Kissick, BC Carthon, M Akce, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, VA Master	01/03/2020
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer	DJ Martini, MR Kline, Y Liu, JM Shabto, MA Williams, AI Khan, C Lewis, H Collins, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, VA Master, MA Bilen	01/02/2020
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. The Lancet. Oncology	RC Doebele, A Drilon, L Paz-Ares, S Siena, AT Shaw, AF Farago, CM Blakely, T Seto, BC Cho, D Tosi, B Besse, SP Chawla, L Bazhenova, JC Krauss, YK Chae, M Barve, I Garrido-Laguna, SV Liu, P Conkling, T John, M Fakih, D Sigal, HH Loong, GL Buchschacher, P Garrido, J Nieva, C Steuer, TR Overbeck, DW Bowles, E Fox, T Riehl, E Chow-Maneval, B Simmons, N Cui, A Johnson, S Eng, TR Wilson, GD Demetri	01/02/2020
Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC). PloS one	NF Saba, AR Dinasarapu, KR Magliocca, B Dwivedi, S Seby, ZS Qin, M Patel, CC Griffith, X Wang, M El-Deiry, CE Steuer, J Kowalski, DM Shin, ME Zwick, ZG Chen	01/01/2020
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials. Investigational new drugs	DJ Martini, Y Liu, JM Shabto, C Lewis, MR Kline, H Collins, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, VA Master, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, MA Bilen	01/12/2019
Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data. The oncologist	MB Bean, Y Liu, R Jiang, CE Steuer, M Patel, MW McDonald, KA Higgins, JJ Beitler, DM Shin, NF Saba	01/12/2019
Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database. Clinical lung cancer	S Tian, X Zhang, R Jiang, RN Pillai, TK Owonikoko, CE Steuer, NF Saba, S Pakkala, PR Patel, CP Belani, FR Khuri, WJ Curran, SS Ramalingam, M Behera, KA Higgins	01/11/2019
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial. The Lancet. Oncology	D Adkins, J Ley, P Neupane, F Worden, AG Sacco, K Palka, JE Grilley-Olson, R Maggiore, NN Salama, K Trinkaus, BA Van Tine, CE Steuer, NF Saba, P Oppelt	01/09/2019
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy. BMC cancer	MA Bilen, JM Shabto, DJ Martini, Y Liu, C Lewis, H Collins, M Akce, H Kissick, BC Carthon, WL Shaib, OB Alese, CE Steuer, C Wu, DH Lawson, R Kudchadkar, VA Master, B El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey	29/08/2019
Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis. Lung cancer (Amsterdam, Netherlands)	MM Awad, GC Leonardi, S Kravets, SE Dahlberg, A Drilon, SA Noonan, DR Camidge, SI Ou, DB Costa, SM Gadgeel, CE Steuer, PM Forde, VW Zhu, Y Fukuda, JW Clark, PA Jänne, T Mok, LM Sholl, RS Heist	01/07/2019
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis. Head & neck	A Mohamed, B Twardy, MA Zordok, K Ashraf, A Alkhoder, K Schrapp, C Steuer, Z Chen, S Pakkala, R Pillai, J Trad Wadsworth, K Higgins, JJ Beitler, SS Ramalingam, TK Owonikoko, FR Khuri, DM Shin, M Behera, NF Saba	01/05/2019
Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx. Cancer	JJ Beitler, JM Switchenko, JJ Dignam, MW McDonald, NF Saba, DM Shin, KR Magliocca, RJ Cassidy, MW El-Deiry, MR Patel, CE Steuer, C Xiao, PA Hudgins, AH Aiken, WJ Curran, QT Le	01/03/2019
Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas. The Laryngoscope	RJ Cassidy, JM Switchenko, MW El-Deiry, RH Belcher, J Zhong, CE Steuer, NF Saba, MW McDonald, DS Yu, TW Gillespie, JJ Beitler	01/02/2019
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy. Cancer	MA Bilen, DJ Martini, Y Liu, C Lewis, HH Collins, JM Shabto, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, VA Master, SS Ramalingam, TK Owonikoko, RD Harvey	01/01/2019
Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy. Cancer	RH Press, C Zhang, RJ Cassidy, MJ Ferris, J Zhong, CE Steuer, RN Pillai, TK Owonikoko, S Kahn, SS Ramalingam, PR Patel, WJ Curran, HG Shu, GL Sica, KA Higgins	01/09/2018
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation. Cancer cell	L Jin, J Chun, C Pan, D Li, R Lin, GN Alesi, X Wang, HB Kang, L Song, D Wang, G Zhang, J Fan, TJ Boggon, L Zhou, J Kowalski, CK Qu, CE Steuer, GZ Chen, NF Saba, LH Boise, TK Owonikoko, FR Khuri, KR Magliocca, DM Shin, S Lonial, S Kang	13/08/2018
Tumor Mutation Burden: Leading Immunotherapy to the Era of Precision Medicine? Journal of clinical oncology : official journal of the American Society of Clinical Oncology	CE Steuer, SS Ramalingam	01/03/2018
A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma. Molecular cancer therapeutics	CE Steuer, CC Griffith, S Nannapaneni, MR Patel, Y Liu, KR Magliocca, MW El-Deiry, C Cohen, TK Owonikoko, DM Shin, ZG Chen, NF Saba	01/03/2018
Health care disparities among octogenarians and nonagenarians with stage III lung cancer. Cancer	RJ Cassidy, X Zhang, JM Switchenko, PR Patel, JW Shelton, S Tian, RH Nanda, CE Steuer, RN Pillai, TK Owonikoko, SS Ramalingam, FG Fernandez, SD Force, TW Gillespie, WJ Curran, KA Higgins	15/02/2018
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients. Annals of oncology : official journal of the European Society for Medical Oncology	J Remon, CE Steuer, SS Ramalingam, E Felip	01/01/2018
Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	MJ Ferris, J Zhong, JM Switchenko, KA Higgins, RJ Cassidy, MW McDonald, BR Eaton, KR Patel, CE Steuer, HM Baddour, AH Miller, DW Bruner, C Xiao, JJ Beitler	01/01/2018
Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer. Cancer	RJ Cassidy, JM Switchenko, E Cheng, R Jiang, J Jhaveri, KR Patel, DG Tanenbaum, MC Russell, CE Steuer, TW Gillespie, MW McDonald, JC Landry	15/11/2017
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis. Clinical lung cancer	HZ Ahmed, Y Liu, K O'Connell, MZ Ahmed, RJ Cassidy, TW Gillespie, P Patel, RN Pillai, M Behera, CE Steuer, TK Owonikoko, SS Ramalingam, WJ Curran, KA Higgins	01/11/2017
A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer. Journal of the National Cancer Institute	DA Goldstein, N Gordon, M Davidescu, M Leshno, CE Steuer, N Patel, SM Stemmer, A Zer	01/11/2017
Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer	KA Higgins, RN Pillai, Z Chen, S Tian, C Zhang, P Patel, S Pakkala, J Shelton, SD Force, FG Fernandez, CE Steuer, TK Owonikoko, SS Ramalingam, JD Bradley, WJ Curran	01/11/2017
Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy. Cancer	RJ Cassidy, X Zhang, PR Patel, JW Shelton, CE Escott, GL Sica, MR Rossi, CE Hill, CE Steuer, RN Pillai, SS Ramalingam, TK Owonikoko, M Behera, SD Force, FG Fernandez, WJ Curran, KA Higgins	01/10/2017
Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base. Cancer	KB Naik, Y Liu, M Goodman, TW Gillespie, A Pickens, SD Force, CE Steuer, TK Owonikoko, SS Ramalingam, K Higgins, JJ Beitler, DM Shin, FF Willingham, B El-Rayes, JC Landry, FG Fernandez, NF Saba	15/09/2017
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review. JAMA oncology	CE Steuer, M Behera, V Ernani, KA Higgins, NF Saba, DM Shin, S Pakkala, RN Pillai, TK Owonikoko, WJ Curran, CP Belani, FR Khuri, SS Ramalingam	01/08/2017
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base. Clinical lung cancer	CE Steuer, M Behera, Y Liu, C Fu, TW Gillespie, NF Saba, DM Shin, RN Pillai, S Pakkala, TK Owonikoko, FR Khuri, SS Ramalingam	01/05/2017
Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base. Cancer	RJ Cassidy, Y Liu, K Patel, J Zhong, CE Steuer, DA Kooby, MC Russell, TW Gillespie, JC Landry	01/03/2017
The End of Nihilism: Systemic Therapy of Advanced Non-Small Cell Lung Cancer. Annual review of medicine	V Ernani, CE Steuer, M Jahanzeb	14/01/2017
An update on larynx cancer. CA: a cancer journal for clinicians	CE Steuer, M El-Deiry, JR Parks, KA Higgins, NF Saba	01/01/2017
Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare Tumor. Oncology	M Evans, Y Liu, C Chen, C Steuer, R Cassidy, J Landry, K Higgins, JJ Beitler, F Willingham, TK Owonikoko, SS Ramalingam, DM Shin, NK Jegadeesh, B El-Rayes, F Fernandez, AM Krasinskas, T Gillespie, NF Saba	01/01/2017
Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy. Frontiers in oncology	M Sayan, RJ Cassidy, JM Switchenko, OA Kayode, NF Saba, CE Steuer, DM Shin, JT Wadsworth, M El-Deiry, M Patel, JJ Beitler, KA Higgins	01/01/2016

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.8	One star One star One star One star One half star	Provider showed concern
4.7	One star One star One star One star One half star	Provider explained things clearly
4.7	One star One star One star One star One half star	Provider discussed treatment options
4.7	One star One star One star One star One half star	Provider included you in decisions
4.7	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	09/03/2024	Dr. Stuer has been amazing and I truly appreciate him.
One star One star One star One star One star	14/01/2024	Dr. Stuer has been amazing and we are very grateful for his help.
One star One star One star One star One star	11/01/2024	Dr. Steurer was very helpful
One star One star One star One star Empty star	21/10/2023	It was a lot of information. Some handouts or a summary would be helpful.
One star One star One star One star One star	17/10/2023	Good
One star One star One star One star One star	03/10/2023	Love Dr Steuer
One star One star One star One star One star	08/09/2023	Very professional & caring Answers all our questions, listens to our concerns Never feel rushed.
One star One star One star One star One half star	25/08/2023	Great
One star One star One star One star One star	06/07/2023	Very thoughtful. Answered all questions.
One star One star One star One star One star	27/06/2023	Very thorough explanation of my options answered all questions and concerns.
One star Empty star Empty star Empty star Empty star	18/06/2023	Care priovider is nurse, right!Care from Dr Steuer is great!
One star One star One star One star One star	15/06/2023	Good communication
One star Empty star Empty star Empty star Empty star	15/06/2023	They would not give me a video visit with oncologist Conor Steuer, even though I was having afib events and did not want to travel to the office. Delayed my treatment.
One star One star One star One star One star	11/06/2023	Listened to our concerns very understanding to the point
One star One star One star One star One star	09/06/2023	I am grateful and fortunate to have Doctor Steuer as my primary oncology doctor He is truly an expert in this field and has helped me through my lung cancer fight and given me back my quality of life. I place full trust in him when it comes to my treatment.
One star One star One star One star One star	21/04/2023	The very best!
One star One star One star One star One star	24/03/2023	All good
One star One star One star One star One star	10/03/2023	Dr Steuer and Lindsey Allen PA are amazing They truly care about me and my health
One star One star One star One star One star	09/03/2023	Dr. Steuer has always been a very Professional and caring Doctor. He communicates well with you and gives you the opportunity to speak as he listens with heartfelt interest. He is truly an Asset to Emory!
One star One star One star One star One star	12/02/2023	I felt that Katy (PA) almost felt too empathetic (good for the patient). A very caring person. All providers met were exceptional.
One star One star One star One star One star	10/12/2022	My care teams was the best ever I had throat cancer my care team were amazing .
One star One star One star One star One star	30/09/2022	I would definitely recommend!
One star One star One star One star One star	20/09/2022	Staff was well prepared to receive me. Had read history and test results. Excellent first impression.
One star One star One star One star One star	15/07/2022	This young lady was very thorough and again had a listening ear with a caring spirit!
One star One star One star One star One star	08/07/2022	Good
One star One star One star One star One star	07/06/2022	Felt very comfortable with the Doctors that attended me